Matches in Wikidata for { <http://www.wikidata.org/entity/Q58593482> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q58593482 description "article scientifique publié en 2018" @default.
- Q58593482 description "article" @default.
- Q58593482 description "im Oktober 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58593482 description "wetenschappelijk artikel" @default.
- Q58593482 description "наукова стаття, опублікована в жовтні 2018" @default.
- Q58593482 name "Regulatory Aspects of the Development of Drugs for Metabolic Bone Diseases - FDA and EMA Perspective" @default.
- Q58593482 name "Regulatory Aspects of the Development of Drugs for Metabolic Bone Diseases - FDA and EMA Perspective" @default.
- Q58593482 type Item @default.
- Q58593482 label "Regulatory Aspects of the Development of Drugs for Metabolic Bone Diseases - FDA and EMA Perspective" @default.
- Q58593482 label "Regulatory Aspects of the Development of Drugs for Metabolic Bone Diseases - FDA and EMA Perspective" @default.
- Q58593482 prefLabel "Regulatory Aspects of the Development of Drugs for Metabolic Bone Diseases - FDA and EMA Perspective" @default.
- Q58593482 prefLabel "Regulatory Aspects of the Development of Drugs for Metabolic Bone Diseases - FDA and EMA Perspective" @default.
- Q58593482 P1433 Q58593482-136957EE-B072-4CCF-B3DB-485E02AE2F3C @default.
- Q58593482 P1476 Q58593482-AB342D40-C84E-46A0-B28D-63F99281F5FD @default.
- Q58593482 P2093 Q58593482-6F1E065C-064F-4D4A-9EDF-523447D5FF12 @default.
- Q58593482 P2860 Q58593482-1F9A91E7-E97C-45A1-9622-CB6809BC981F @default.
- Q58593482 P2860 Q58593482-6843AFDE-F5E2-4D14-BE8A-EA474E069428 @default.
- Q58593482 P2860 Q58593482-A1E9EC4D-A0F5-4DDA-B842-9328A0277F83 @default.
- Q58593482 P2860 Q58593482-A2F39780-67E4-43C2-91B6-C13D5DD4BEF9 @default.
- Q58593482 P2860 Q58593482-C3C0B444-A12F-428E-B205-44E46E8F7C06 @default.
- Q58593482 P2860 Q58593482-D09DF775-2CE2-4EFA-BF3A-0BDEE28AA211 @default.
- Q58593482 P2860 Q58593482-FC7A28C2-3AD1-468C-B5EE-FF40AC1CC238 @default.
- Q58593482 P2860 Q58593482-FFF603DA-CD69-4952-9D6B-F2F5EB7E17A0 @default.
- Q58593482 P304 Q58593482-A1F4E80D-CD44-421A-8208-989C83A55EB7 @default.
- Q58593482 P31 Q58593482-E4FDA6D5-C057-4FC7-BA2C-613CE2E08707 @default.
- Q58593482 P356 Q58593482-5891CA3E-4C3D-4D3C-9008-A42D63B9FFD2 @default.
- Q58593482 P407 Q58593482-D0C5C7DB-C200-4902-B322-78C980664CDC @default.
- Q58593482 P433 Q58593482-53414867-C769-41F8-BFC1-2196F4335E9A @default.
- Q58593482 P478 Q58593482-6422D018-DC09-4339-BBCB-09FC5890F80B @default.
- Q58593482 P50 Q58593482-4CEE44BF-39FB-4ACA-A8CF-E43062EC8046 @default.
- Q58593482 P50 Q58593482-7ECA3D83-4D24-4BD7-BE48-6DE442CAD2CA @default.
- Q58593482 P577 Q58593482-69376442-EC30-4A4C-8D0C-69CACF130971 @default.
- Q58593482 P698 Q58593482-3D3C5A81-1536-4B38-82D2-A89BEAD25F43 @default.
- Q58593482 P932 Q58593482-6D60A11B-DFFC-465B-9C26-5A72E50D5B6A @default.
- Q58593482 P356 BCP.13791 @default.
- Q58593482 P698 30335197 @default.
- Q58593482 P1433 Q176044 @default.
- Q58593482 P1476 "Regulatory aspects of the development of drugs for metabolic bone diseases - FDA and EMA perspective" @default.
- Q58593482 P2093 "Heidi Janssen" @default.
- Q58593482 P2860 Q28254528 @default.
- Q58593482 P2860 Q28278665 @default.
- Q58593482 P2860 Q29619487 @default.
- Q58593482 P2860 Q34250632 @default.
- Q58593482 P2860 Q34537630 @default.
- Q58593482 P2860 Q38666521 @default.
- Q58593482 P2860 Q40579997 @default.
- Q58593482 P2860 Q61684912 @default.
- Q58593482 P304 "1208-1212" @default.
- Q58593482 P31 Q13442814 @default.
- Q58593482 P356 "10.1111/BCP.13791" @default.
- Q58593482 P407 Q1860 @default.
- Q58593482 P433 "6" @default.
- Q58593482 P478 "85" @default.
- Q58593482 P50 Q58236964 @default.
- Q58593482 P50 Q92379527 @default.
- Q58593482 P577 "2018-12-03T00:00:00Z" @default.
- Q58593482 P698 "30335197" @default.
- Q58593482 P932 "6533422" @default.